GuangYuYuan Chinese Herbal Medicine Co., Ltd. (600771.SS)
CNY 19.33
(1.52%)
CNY 19.33
(1.52%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 215.49 Million | 253.42 Million | 81.36 Million | -75.52 Million | -140.81 Million | -297.97 Million |
| Net Income | 92.85 Million | -417.85 Million | -332.42 Million | 29.57 Million | 137.34 Million | 394.05 Million |
| Depreciation & Amortization | 46.01 Million | 39.25 Million | 38.38 Million | 34.68 Million | 31.98 Million | 13.14 Million |
| Deferred income taxes | -7.18 Million | -12.51 Million | -369.6 Thousand | -16.46 Million | -6.52 Million | -8.67 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 30.64 Million | 540.68 Million | 370.12 Million | -235.86 Million | -401.07 Million | -758.04 Million |
| Other non-cash items | 19.49 Million | 91.34 Million | 5.28 Million | 96.08 Million | 90.92 Million | 52.87 Million |
| Investing Cash Flow | -1.18 Million | -7.4 Million | -17.88 Million | -58.66 Million | -87.48 Million | 81.21 Million |
| Investments in PPE | -2.51 Million | -8.66 Million | -18.19 Million | -49.64 Million | -87.36 Million | -200.44 Million |
| Acquisitions | 233.23 Thousand | 33.31 Thousand | 512.70 | 50.7 Million | 87.38 Million | 2 Million |
| Investment purchases | - | -33.31 Thousand | -2 Million | -16.7 Million | -1.1 Million | - |
| Sales/Maturities of investments | 1.09 Million | 1.22 Million | 2.3 Million | 6.61 Million | 960.35 Thousand | 305.65 Million |
| Other Investing Activities | 1.32 Million | 33.31 Thousand | 0.02 | -49.64 Million | -87.36 Million | -23.99 Million |
| Financing Cash Flow | -201.31 Million | -102.98 Million | -107.97 Million | 120.77 Million | 261.95 Million | 60.98 Million |
| Debt repayment | -179.2 Million | -258.06 Million | -309.8 Million | -207.42 Million | -191.56 Million | -332.05 Million |
| Dividends payments | -14.33 Million | -19.79 Million | -18.31 Million | -11.03 Million | -12.73 Million | -27.18 Million |
| Common Stock Repurchased | - | - | - | - | -51.22 Million | -1.00 |
| Common Stock Issuance | - | - | - | - | 51.22 Million | - |
| Other Financing Activities | -7.77 Million | 174.86 Million | 220.13 Million | 339.24 Million | 466.25 Million | 420.23 Million |
| Accounts receivables | 221.08 Million | 371.88 Million | 228.78 Million | -273.11 Million | -201.84 Million | -622.39 Million |
| Accounts payables | -25.65 Million | 240.94 Million | 155.61 Million | -107.41 Million | -41.74 Million | 64.03 Million |
| Inventory | -157.6 Million | -59.62 Million | 9.76 Million | 161.13 Million | -150.95 Million | -191 Million |
| Other working capital | -32.84 Million | -12.51 Million | -24.03 Million | -16.46 Million | -6.52 Million | -567.03 Million |
| Cash at beginning of period | 243.94 Million | 100.91 Million | 145.41 Million | 158.83 Million | 125.17 Million | 280.94 Million |
| Cash at end of period | 256.95 Million | 243.94 Million | 100.91 Million | 145.41 Million | 158.83 Million | 125.17 Million |
| Capital Expenditure | -2.51 Million | -8.66 Million | -18.19 Million | -49.64 Million | -87.36 Million | -200.44 Million |
| Effect of forex changes on cash | - | 0.38 | 0.18 | - | - | - |
| Net cash flow / Change in cash | 13 Million | 143.02 Million | -44.49 Million | -13.41 Million | 33.65 Million | -155.77 Million |
| Free Cash Flow | 212.98 Million | 244.76 Million | 63.17 Million | -125.17 Million | -228.18 Million | -498.41 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | 18.29 Million | 41.3 Million | 65.59 Million | 92.85 Million | 14.42 Million |
| Depreciation & Amortization | - | 11.84 Million | 11.84 Million | 46.01 Million | 46.01 Million | -21.45 Million |
| Deferred income taxes | - | - | - | - | -7.18 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -83.19 Million | - | 63.48 Million | 30.64 Million | -160.28 Million |
| Other non-cash items | - | 26.38 Million | 88.1 Million | -319.1 Million | 19.49 Million | 248.3 Million |
| Investing Cash Flow | -1.7 Million | -1.77 Million | 1.18 Million | -913.61 Thousand | -1.18 Million | -466.22 Thousand |
| Investments in PPE | -1.7 Million | -1.82 Million | -378.46 Thousand | -915.73 Thousand | -2.51 Million | -466.22 Thousand |
| Acquisitions | - | 43 Thousand | - | 2120.00 | 233.23 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 1.56 Million | - | 1.09 Million | - |
| Other Investing Activities | - | 43 Thousand | 1.56 Million | 2120.00 | 1.32 Million | - |
| Financing Cash Flow | -1.85 Million | -248.74 Million | -4.1 Million | 176.02 Million | -201.31 Million | -120.5 Million |
| Debt repayment | - | -245.6 Million | - | -100 Thousand | -179.2 Million | -30 Million |
| Dividends payments | - | -1.28 Million | -2.66 Million | -2.66 Million | -14.33 Million | -2.95 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.85 Million | 151.62 Thousand | -1.43 Million | 178.79 Million | -7.77 Million | -87.55 Million |
| Accounts receivables | - | 41.1 Million | - | 221.08 Million | 221.08 Million | -190.13 Million |
| Accounts payables | - | - | - | - | -25.65 Million | - |
| Inventory | - | -124.29 Million | - | -157.6 Million | -157.6 Million | 29.84 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 165.77 Million | 385.21 Million | 256.95 Million | 225.85 Million | 243.94 Million | 265.83 Million |
| Cash at end of period | 135.99 Million | 167.53 Million | 383.44 Million | 256.95 Million | 256.95 Million | 225.85 Million |
| Capital Expenditure | -1.7 Million | -1.82 Million | -378.46 Thousand | -915.73 Thousand | -2.51 Million | -466.22 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | 0.24 |
| Net cash flow / Change in cash | -29.77 Million | -217.67 Million | 126.49 Million | 31.09 Million | 13 Million | -39.98 Million |
| Free Cash Flow | -1.7 Million | 31.02 Million | 129.03 Million | -144.93 Million | 212.98 Million | 80.52 Million |
TRCK
8295
688038
SUDARSCHEM
600516
CLS-B